Chapter 18.3
Metastatic Tumours
Masamichi Kojiro,
Antoni Castells,
Humphrey J.F. Hodgson,
Masamichi Kojiro
Search for more papers by this authorAntoni Castells
Search for more papers by this authorHumphrey J.F. Hodgson
Search for more papers by this authorMasamichi Kojiro,
Antoni Castells,
Humphrey J.F. Hodgson,
Masamichi Kojiro
Search for more papers by this authorAntoni Castells
Search for more papers by this authorHumphrey J.F. Hodgson
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
Summary
This chapter contains section titled:
-
Metastatic Liver Disease
-
Carcinoid Tumours
References
- Craig JR Peters RL Edmondson HA (1988) Tumors of the liver and intrahepatic bile ducts. In: JR Craig, RL Peters, HA Edmondson (eds) Atlas of Tumor Pathology, 2nd series, Fascicle 26, Washington, DC: Armed Forces Institute of Pathology, pp. 256–267.
- Pickren JW Tsukada Y Lane WW (1982) Liver metastasis: analysis of autopsy data. In: L Weiss, HA Gilbert (eds) Liver Metastasis. Boston: Hall Medical Publishers, pp. 2–18.
- Lieber MM (1957) Rare occurrence of metastatic carcinoma in cirrhotic liver. Am J Med Sci 233, 145–152.
- Lisa JR Solomon C Gordon EJ (1942) Secondary carcinoma in cirrhosis of liver. Am J Pathol 18, 137–140.
- Gall E (1960) Primary and metastatic carcinoma of the liver. Relationship to hepatic cirrhosis. Arch Pathol 70, 226–232.
-
Melato M
Laurino L
Mucli E et al.
(1989)
Relationship between cirrhosis, liver cancer, and hepatic metastases: an autopsy study.
Cancer
64,
455–459.
10.1002/1097-0142(19890715)64:2<455::AID-CNCR2820640219>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- Fisher E Hellstrom HR Fisher B (1960) Rarity of hepatic metastasis in cirrhosis — a misconception. JAMA 174, 366–369.
-
Paget S
(1889)
The distribution of secondary growths in cancer of the breast.
Lancet
1,
571–573.
10.1016/S0140-6736(00)49915-0 Google Scholar
- Kohn EC Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55, 1856–1862.
- Chambers AF Groom AC MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nature Rev 2, 563–572.
- O'Reilly MS Holmgren L Shing I et al. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328.
- Wyckoff JB Jones JG Gondeelis JS et al. (2000) A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 60, 2504–2511.
- Stetler-Stevenson WG Liotta LA Kleiner DE (1993) Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7, 1434–1441.
- Chambers AF Matrisian LM (1997) Changing views of the role of matrix metalloproteineses in metastasis. J Natl Cancer Inst 89, 1260–1270.
- Ogawa M Ikeuchi K Watanabe M et al. (2005) Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach. Hepatogastroenterology 52, 875–880.
- Radinsky R (1995) Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metast Rev 14, 323–338.
- Radinsky R (1995) Molecular mechanisms for organ-specific colon carcinoma metastasis. Eur J Cancer 31A, 1091–1095.
- Müller A Homy S Soto H et al. (2001) Involvement of chemochine receptors in breast cancer metastasis. Nature 410, 50–56.
- Holmgren L O'Reilly MS Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1, 117–118.
- Qizilbash A Kontozoglou T Sianos JM et al. (1987) Hepar lobatum associated with chemotherapy and metastatic breast cancer. Arch Pathol Lab Med 111, 58–61.
- Rullier A Le Bail B Fawaz R et al. (2000) Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastases. Am J Surg Pathol 24, 870–876.
- Kemeny N Braun DW Jr (1983) Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenises level, performance status, and white blood cell count. Am J Med 74, 786–794.
- Lahr CJ Soong SJ Cloud G et al. (1983) A multifactorial analyses of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1, 720–726.
- Wanebo JH Stearna M Schwarts MK (1978) Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg 188, 481–493.
- Hohenberger P Schlag PM Gerneth T et al. (1994) Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Ann Surg 219, 135–143.
- Doci R Gennari L Bignami P et al. (1991) One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78, 797–780.
- Sheiner PA Brower ST (1994) Treatment of metastatic cancer to the liver. Semin Liver Dis 14, 169–177.
- Igawa S Sakai K Kinoshita H et al. (1985) Intraoperative sonography: clinical usefulness in liver surgery. Radiology 156, 473–478.
- Bennett WF Bova JG (1990) Review of hepatic imaging and a problem-oriented approach to liver masses. Hepatology 12, 761–775.
- Sitzmann JV Coleman J Pitt HA et al. (1990) Preoperative assessment of malignant hepatic tumors. Am J Surg 159, 137–142.
- Nelson RC Chezmar JL Sugarbaker PH et al. (1989) Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 172, 27–34.
- Stark DD Wittenberg J Butch RJ et al. (1987) Hepatic metastases: randomized, controlled comparison of detection with MR imaging and CT. Radiology 165, 399–406.
- Zhuang H Sinha P Pourdehnad M et al. (2000) The role of positron emission tomography with fluorine-18-deoxyglucose in identifying cancer metastases to liver. Nucl Med Commun 9, 793–798.
- Frohlich A Diederichs CG Stalb L et al. (1999) Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 40, 250–255.
- Steele G Jr, Bleday R Mayer RJ et al. (1991) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumour Study Group Protocol, 6584. J Clin Oncol 9, 1105–1112.
- Makuuchi M Hasegawa H Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161, 346–350.
- Butler J Attiyeh FF Daly JM (1986) Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 102, 109–113.
- Iwatsuki S Sheahan DG Starzl TE (1989) The changing face of hepatic resection. Curr Problems Surg 26, 283–379.
- Curley SA Izzo F Abdalla E et al. (2004) Surgical treatment of colorectal cancer metastasis. Cancer Metast Rev 23, 165–182.
- Ruers T Bleichrodt RP (2002) Treatment of liver metastases, an update on the possibility and results. Eur J Cancer 38, 1023–1033.
- Oshowo A Gilliamas A Harrison E et al. (2003) Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90, 1240–1243.
- Registry of Hepatic Metastases (1988) Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications from resection. Surgery 103, 278–288.
- Evard S Becouarn Y Fonck M et al. (2004) Surgical treatment of liver metastases by radiofrequency ablation, resection, or combination. Eur J Surg 39, 399–406.
- Parlkh AA Curley SA Fornage BD et al. (2002) Radiofrequency ablation of hepatic metastases. Semin Oncol 29, 168–182.
- Lau TN Lo RH Tan BS (2003) Colorectal hepatic metastases: role of radiofrequency ablation. Ann Acad Med Sing 32, 21–28.
- Gazelle GS McMahon PM Beinfeld MT et al. (2004) Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology 233, 729–739.
- Grage TB Vassilopoulos PP Shingleton WW et al. (1979) Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil vs intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Surgery 86, 550–555.
- Machover D Goldschmidt E Chollet P et al. (1986) Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 4, 685–696.
- Petrelli N Douglass HO Jr, Herrera L et al. (1989) The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 7, 1419–1426.
- Ardalan B Chua L Tian EM et al. (1991) A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 9, 625–630.
- Balch CM Urist MM McGregor ML (1983) Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patients. Am J Surg 145, 285–290.
-
Reed ML
Vaitevicius VK
Al-Sarraf M et al.
(1981)
The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol.
Cancer
47,
402–409.
10.1002/1097-0142(19810115)47:2<402::AID-CNCR2820470231>3.0.CO;2-B CAS PubMed Web of Science® Google Scholar
-
Niederhuber JE
Ensminger W
Gyves J et al.
(1984)
Regional chemotherapy of colorectal cancer metastatic to the liver.
Cancer
53,
1336–1343.
10.1002/1097-0142(19840315)53:6<1336::AID-CNCR2820530620>3.0.CO;2-O CAS PubMed Web of Science® Google Scholar
- Sugihara K (1995) Continuous hepatic arterial infusion of 5-fluouracil for unresectable colorectal liver metastases: phase II study. Surgery 117, 624–628.
- Bavisotto LM Patel NH Althaus SJ et al. (1999) Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion of 5-fluouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104). Clin Cancer Res 5, 95–109.
- Lang H Schlitt HJ Schmidt H et al. (1999) Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas — a single center experience with ten patients. Arch Surg 384, 370–377.
- Lang H Oldhafer KJ Weimann A et al. (1997) Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 225, 347–354.
- Fernandez JA Robles R Marin C et al. (2003) Role of liver transplantation in the management of metastatic neuroendocrine tumors. Transplant Proc 35, 1832–1833.
- Florman S Toure B Kim L et al. (2004) Liver transplantation for neuroendocrine tumors. J Gastrointest Surg 8, 208–212.
- Okuda K Kojiro M Okuda H (1997) Neoplasms of the liver. In: L Schiff, ER Schiff (eds) Diseases of the Liver, 7th edn. Philadelphia, PA: Lippincott Williams & Wilkins.
- Langley K (1994) The neuroendocrine concept today. Ann NY Acad Sci 733, 1–17.
- Lips CJ Lentjes EG Hoppener JW (2003) The spectrum of carcinoid tumours and carcinoid syndromes. Ann Clin Biochem 40 (Pt 6), 612–627.
- Leotlela PD Jauch A Holtgreve-Grez H et al. (2003) Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer 10 (4), 437–450.
- Soga J (2003) Carcinoids and their variant endocrinomas. An analysis of 11 842 reported cases. J Exp Clin Cancer Res 22 (4), 517–530.
- Modlin IM Lye KD Kidd M (2003) A 5-decade analysis of 13 715 carcinoid tumors. Cancer 97 (4), 934–959.
- Iwao M Nakamuta M Enjoji M et al. (2001) Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit 7 (4), 746–750.
- de Herder WW Hofland LJ van der Lely AJ et al. (2003) Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours. Endocr Relat Cancer 10 (4), 451–458.
- Griffiths DF Williams GT Williams ED (1987) Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes. Q J Med 64 (245), 769–782.
- Modlin IM Kidd M Latich I et al. (2005) Current status of gastrointestinal carcinoids. Gastroenterology 128 (6), 1717–1751.
- Rorstad O (2005) Prognostic indicators for carcinoid neuroendocrine tumours of the gastrointestinal tract. J Surg Oncol 89, 151–160.
- Eriksson B Oberg K Stridsberg M (2000) Tumor markers in neuroendocrine tumors. Digestion 62 (Suppl 1), 33–38.
- Ardill JE Erikkson B (2003) The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut. Endocr Relat Cancer 10 (4), 459–462.
- Kaltsas G Rockall A Papadogias D et al. (2004) Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 151 (1), 15–27.
- Shapiro B Sisson JC Shulkin BL et al. (1995) The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuroendocrine tumors. Q J Nucl Med 39 (4 Suppl 1), 3–8.
- Warner RR O'dorisio TM (2002) Radiolabeled peptides in diagnosis and tumor imaging: clinical overview. Semin Nucl Med 32 (2), 79–83.
- Sundin A Eriksson B Bergstrom M et al. (2004) PET in the diagnosis of neuroendocrine tumors. Ann NY Acad Sci 1014, 246–257.
- De la Torre J Garcia A Castellvi J et al. (2004) Primary ovarian trabecular carcinoid tumour: a case report with an immunohistochemical study and a review of the literature. Arch Gynecol Obstet 270 (4), 274–277.
- Hage R de la Riviere AB Seldenrijk CA et al. (2003) Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol 10 (6), 697–704.
- Barakat MT Meeran K Bloom SR (2004) Neuroendocrine tumours. Endocr Relat Cancer 11 (1), 1–18.
- Modlin IM Tang LH (1999) Cell and tumour biology of the gastric enterochromaffin-like cell. Ital J Gastroenterol Hepatol 31 (Suppl 2), S117–130.
- Bell HK Poston GJ Vora J et al. (2005) Cutaneous manifestations of the malignant carcinoi. syndrome. Br J Dermatol 152 (1), 71–75.
- Hansen MB Dresner LS Wait RB (1998) Profile of neurohumoral agents on mesenteric and intestinal blood flow in health and disease. Physiol Res 47 (5), 307–327.
- Fox DJ Khattar RS (2004) Carcinoid heart disease: presentation, diagnosis, and management. Heart 90 (10), 1224–1228.
- Lee DF Lepler LS (1999) Severe intrapulmonary shunting associated with metastatic carcinoid. Chest 115 (4), 1203–1207.
- Plonk JW Feldman JM (1974) Carcinoid arthropathy. Arch Intern Med 134 (4), 651–654.
- Calhoun K Toth-Fejel S Cheek J et al. (2003) Serum peptide profiles in patients with carcinoid tumors. Am J Surg 186 (1), 28–31.
- Sutton R Doran HE Williams EM et al. (2003) Surgery for midgut carcinoid. Endocr Relat Cancer 10 (4), 469–481.
- Wymenga AN de Vries EG Leijsma MK et al. (1998) Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome. Eur J Cancer 34 (8), 1293–1294.
- Le Treut YP Delpero JR Dousset B et al. (1997) Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg 225 (4), 355–364.
- Kinney MA Warner ME Nagorney DM et al. (2001) Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours. Br J Anaesth 87 (3), 447–452.
- Ahlman H Nilsson O Olausson M (2004) Interventional treatment of the carcinoid syndrome. Neuroendocrinology 80 (Suppl 1), 67–73.
- Norton JA Kerlan RK (2003) Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary. Cancer J 9 (4), 241–243.
- Henn AR Levine EA McNulty W et al. (2003) Percutaneous radio-frequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes. AJR Am J Roentgenol 181 (4), 1005–1010.
- O'Toole D Maire F Ruszniewski P (2003) Ablative therapies for liver metastases of digestive endocrine tumours. Endocr Relat Cancer 10 (4), 463–468.
- Warren WH Gould VE (1990) Long-term follow-up of classical bronchial carcinoid tumors. Clinicopathologic observations. Scand J Thorac Cardiovasc Surg 24 (2), 125–130.
- Oberg K (2001) Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 12 (Suppl 2), S111–114.
- Safford SD Coleman RE Gockerman JP et al. (2004) Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients. Cancer 101 (9), 1987–1993.
- Tomassetti P Migliori M Campana D et al. (2003) The role of somatostatin analogs in the management of carcinoid tumors. J Endocrinol Invest 26 (8 Suppl), 79–81.
- Leong WL Pasieka JL (2002) Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature. J Surg Oncol 79 (3), 180–187.
